SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Bio-Path Holdings, Inc. (BPTH) , forward earnings yield 2,500.00%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 0.0
Overall SharesGrow Score: 36/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BPTH
Valuation Multiples
P/E (TTM)0.0
Forward P/E0.0
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-4.12
Forward EPS (Est.)$1.50
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield2,500.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-243.61 |
$0.00 |
$-5.47M |
- |
| 2016 |
$-291.26 |
$13K |
$-6.75M |
-51923.1% |
| 2017 |
$-278.69 |
$37K |
$-7.02M |
-18981.1% |
| 2018 |
$-287.54 |
$0.00 |
$-8.58M |
- |
| 2019 |
$-64.02 |
$0.00 |
$-8.51M |
- |
| 2020 |
$-56.44 |
$0.00 |
$-10.86M |
- |
| 2021 |
$-31.04 |
$0.00 |
$-10.44M |
- |
| 2022 |
$-38.03 |
$0.00 |
$-13.84M |
- |
| 2023 |
$-33.64 |
$0.00 |
$-16.08M |
- |
| 2024 |
$-4.12 |
$0.00 |
$-9.89M |
- |
